DIFFERENTIAL EXPRESSION OF THE FIBRONECTIN ISOFORM CONTAINING THE ED-B ONCOFETAL DOMAIN IN NORMAL HUMAN FIBROBLAST CELL-LINES ORIGINATING FROM DIFFERENT TISSUES

被引:39
作者
BORSI, L [1 ]
BALZA, E [1 ]
ALLEMANNI, G [1 ]
ZARDI, L [1 ]
机构
[1] IST NAZL RIC CANC,CELL BIOL LAB,VIALE BENEDETTO XV 10,I-16132 GENOA,ITALY
关键词
D O I
10.1016/0014-4827(92)90466-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fibronectin (FN) polymorphism is due both to alternative splicing of three sequences (ED-A, ED-B, and IIICS) of the primary transcript and to post-translational modifications. The FN isoform containing the ED-B sequence (B-FN), while having an extremely restricted distribution in normal adult tissues, has a high expression in fetal and tumor tissues. On a panel of non-fetal skin, fetal skin, and fetal lung fibroblast cell lines we have studied, through S1-nuclease protection analysis, the expression of the ED-B containing FN mRNA as well as the expression of the ED-B containing FN isoform through immunoblotting and immunofluorescence techniques, using domain specific monoclonal antibodies. The results show that the expression of B-FN in the different fibroblast cell lines has an extremely great variability depending on the developmental stage of the donor and on the tissue of origin. Moreover, we found that SV-40-transformed fibroblasts present a higher expression of B-FN mRNA with respect to their normal counterparts. An increase in the relative amount of the B-FN isoform in normal human fibroblasts was also obtained by treatment with transforming growth factor-β. © 1992.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 66 条
[1]   PARACRINE INFLUENCE OF HUMAN-BREAST STROMAL FIBROBLASTS ON BREAST EPITHELIAL-CELLS - SECRETION OF A POLYPEPTIDE WHICH STIMULATES REDUCTIVE 17-BETA-ESTRADIOL DEHYDROGENASE-ACTIVITY [J].
ADAMS, EF ;
NEWTON, CJ ;
TAIT, GH ;
BRAUNSBERG, H ;
REED, MJ ;
JAMES, VHT .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (01) :119-122
[2]   PERICELLULAR MATRIX IN MALIGNANT TRANSFORMATION [J].
ALITALO, K ;
VAHERI, A .
ADVANCES IN CANCER RESEARCH, 1982, 37 :111-158
[3]   TRANSFORMING GROWTH-FACTOR BETA-REGULATES THE LEVELS OF DIFFERENT FIBRONECTIN ISOFORMS IN NORMAL HUMAN CULTURED FIBROBLASTS [J].
BALZA, E ;
BORSI, L ;
ALLEMANNI, G ;
ZARDI, L .
FEBS LETTERS, 1988, 228 (01) :42-44
[4]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[5]   CELL TYPE SPECIFIC TRANS-ACTING FACTORS ARE INVOLVED IN ALTERNATIVE SPLICING OF HUMAN FIBRONECTIN PRE-MESSENGER RNA [J].
BARONE, MV ;
HENCHCLIFFE, C ;
BARALLE, FE ;
PAOLELLA, G .
EMBO JOURNAL, 1989, 8 (04) :1079-1085
[6]   A NOVEL METALLOPROTEINASE GENE SPECIFICALLY EXPRESSED IN STROMAL CELLS OF BREAST CARCINOMAS [J].
BASSET, P ;
BELLOCQ, JP ;
WOLF, C ;
STOLL, I ;
HUTIN, P ;
LIMACHER, JM ;
PODHAJCER, OL ;
CHENARD, MP ;
RIO, MC ;
CHAMBON, P .
NATURE, 1990, 348 (6303) :699-704
[7]  
BENNETT VD, 1991, J BIOL CHEM, V266, P5918
[8]   TRANSFORMING GROWTH-FACTOR-BETA REGULATES THE SPLICING PATTERN OF FIBRONECTIN MESSENGER-RNA PRECURSOR [J].
BORSI, L ;
CASTELLANI, P ;
RISSO, AM ;
LEPRINI, A ;
ZARDI, L .
FEBS LETTERS, 1990, 261 (01) :175-178
[9]   STRUCTURAL DIFFERENCES IN THE CELL BINDING REGION OF HUMAN FIBRONECTIN MOLECULES ISOLATED FROM CULTURED NORMAL AND TUMOR-DERIVED HUMAN-CELLS [J].
BORSI, L ;
ALLEMANNI, G ;
CASTELLANI, P ;
ROSELLINI, C ;
DIVINCI, A ;
ZARDI, L .
FEBS LETTERS, 1985, 192 (01) :71-74
[10]   MONOCLONAL-ANTIBODIES IN THE ANALYSIS OF FIBRONECTIN ISOFORMS GENERATED BY ALTERNATIVE SPLICING OF MESSENGER-RNA PRECURSORS IN NORMAL AND TRANSFORMED HUMAN-CELLS [J].
BORSI, L ;
CARNEMOLLA, B ;
CASTELLANI, P ;
ROSELLINI, C ;
VECCHIO, D ;
ALLEMANNI, G ;
CHANG, SE ;
TAYLORPAPADIMITRIOU, J ;
PANDE, H ;
ZARDI, L .
JOURNAL OF CELL BIOLOGY, 1987, 104 (03) :595-600